Broad-Based Demand & Talent Investments Aid FCN Amid Stiff Rivalry

FTI Consulting reported broad Q2 2026 revenue growth, led by Technology at 18.4% and Corporate Finance at 8.5%, while operating cash flow rose to $152.3 million from $55.7 million and free cash flow increased to $141.0 million from $38.3 million. The company repurchased $390.9 million of stock in Q2 after $858.7 million in 2025, supporting per-share earnings. AI-related consulting demand and talent additions support the multiyear outlook, but intense competition may pressure pricing and margins, while FCN's lack of a dividend limits appeal for income investors.

Analysis

FCN’s investable question is whether incremental senior hiring converts into utilization and realized rate growth faster than compensation inflation. In expert consulting, adding capacity before demand is contracted can depress margins for several quarters; the key confirmation is segment margin expansion alongside utilization, not revenue growth alone. The most defensible upside sits in countercyclical restructuring, investigations and disputes, where a softer credit cycle can lift demand even if transaction advisory slows.

AI is not uniformly additive: it should raise demand for regulatory, IP and forensic mandates, but it can also compress lower-value document-review and e-discovery labor. FCN’s differentiated upside requires monetizing AI as senior-led advisory work rather than passing productivity savings to clients. Public comparables CRAI and HURN offer cleaner read-throughs on expert-consulting pricing; software-enabled legal workflow vendors such as RELX and THOMSON REUTERS could capture more of the recurring AI economics than FCN.

The scale of recent repurchases makes capital allocation a more immediate EPS driver than the lack of a dividend, but also raises the hurdle for organic returns: buying stock at an elevated multiple can mask slowing underlying EPS. Over the next 1-3 months, watch quarterly utilization, compensation/revenue, and net hiring versus voluntary attrition. Over 6-18 months, a widening restructuring pipeline or sustained regulatory enforcement cycle would support multiple expansion; a rebound in M&A without equivalent share gains would favor larger advisory platforms and weaken FCN’s relative setup.

Consensus appears too willing to treat broad demand as proof of operating leverage. The falsifier for a cautious view is two consecutive quarters of margin expansion with stable senior-staff utilization and rate realization; conversely, a material rise in compensation ratio or a slower repurchase pace would expose the dependence of per-share growth on capital returns.

Key Decisions for Investors

• Maintain FCN as a watch/hold rather than initiate on this update; add only after the next earnings release confirms utilization and segment-margin expansion, not merely top-line growth. Thesis fails if compensation growth outpaces revenue or management reduces repurchase authorization.
• For a 3-6 month relative-value expression, consider long FCN / short HURN or CRAI only if FCN demonstrates superior margin conversion while peers show flat utilization. Size modestly because all three are exposed to the same litigation, restructuring and transaction-advisory cycle; close if FCN’s margin gap fails to emerge over two reports.
• Monitor credit-stress indicators and restructuring backlog as a 6-18 month catalyst. If high-yield spreads widen materially while FCN’s Corporate Finance utilization rises, increase exposure: restructuring demand has higher urgency and generally better pricing than transaction work.
• Do not use TBI or TT as substitutes for FCN. TBI is a labor-cycle exposure and TT is an HVAC/capital-expenditure compounder; their favorable analyst rankings do not create a fundamental read-through to FCN’s advisory margins or capital-return durability.